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ABSTRAK 
 
Latar belakang 
Berdasarkan kepada banyak kajian-kajian yang dijalankan sebelum ini mendapati bahawa 
Channa Striatus (Ikan Haruan) dapat membantu mempercepatkan proses penyembuhan luka 
dan juga mampu mengurangkan tahap kesakitan pada luka. Walau bagaimana pun, setakat ini 
kajian-kajian ini hanyalah dijalankan terhadap haiwan . Masih belum terdapat kajian yang 
khusus tentang kesan Channa Striatus (Ikan Haruan) terhadap kualiti penyembuhan luka dari 
segi kosmetik dan pengawalan tahap kesakitan kepada manusia. Jadi, satu kajian prospektif 
tentang kesan semburan ekstrak ikan Haruan terhadap luka pembedahan bersih di jalankan. 
 
Metodologi 
Seramai 102 orang yang menjalani pembedahan elektif yang dikategorikan bersih telah 
dirawakkan kepada dua kumpulan A dan B . Kumpulan A menerima semburan ikan haruan 
terhadap luka pembedahannya (n=51) manakala kumpulan B menerima semburan placebo 
(n=51). Semua luka pesakit di nilai pada minggu ke 2, 4 dan 6 dari segi kosmetik berdasarkan 
3 sistem pemarkahan iaitu VACS (Visual Analogue Cosmetic Scale),WES (Wound 
Evaluation Scale),VSS (Vancouver Scar Scale). Tahap kesakitan pada luka pembedahan turut 
dinilai berdasarkan kepada system pemarkahan VAPS (Visual Analogue Pain Score). 
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Keputusan 
 
Daripada 102 pesakit, seramai 21 orang pesakit telah tercicir daripada kajian kerana tidak 
dapat menghadiri temujani susulan. Analisis terhadap 81 pesakit menggunakan kaedah 
‘Repeated measure ANOVA didapati bahawa tahap kesakikatan menggunakan VAPS adalah 
lebih baik bagi pesakit yang menerima ekstrak haruan berbanding pesakit yang menerima 
placebo. RM Anova:  (F-stat(df) = 4.80 (2), p-value = 0.010). Analisa bagi pesakit yang 
mendapat rawatan semburan pati ekstrak ikan haruan turut menunjukkan kesan kosmetik 
yang lebih baik berdasarkan system VACS, (F-stat(df) = 2.68 (2) , p-value <0.001), WES (F-
stat(df) = 3.09 (2), p-value = 0.048) and VSS , F-stat(df) = 1.72 (2) , p-value = 0.011).  
 
Kesimpulan 
 
Hasil kajian mendapati bahawa luka bersih yang di rawat dengan semburan ekstrak haruan 
adalah lebih baik berbanding dengan placebo dari segi kosmetik dan tahap kesakitan pada 
minggu ke 2, ke 4 dan minggu ke 6. 
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ABSTRACT 
 
Background  
Channa striatus (Haruan), a fresh water fish indigenous to many tropical countries have long 
been regarded as valuable food fish in the Far East. Several studies showed, the Haruan did 
contain all the essential amino acids and fatty acids uniquely capable of accelerating the 
wound healing and it has anti-nociceptive effect. However so far no human study been done 
to assess the effectiveness of Channa striatus in wound healing. A prospective randomize 
controlled trial has been conducted on the effect of Channa striatus Spray versus placebo on 
clean wound to assess its pain control effect and cosmetic outcome.   
 
 
Methodology 
Hundred and two patients (102) underwent clean elective surgery; post-operatively they are 
randomized into two group. One group received Channa striatus Extract spray (n=51) 
another group receive placebo (n=51) on daily basis for 2 week. Then they were follow up on 
2nd, 4th and 6th week to assess the pain control effect based on Visual Analog Pain Score 
(VAPS)  and cosmetic outcome based on Visual Analogue Cosmetic Scale (VACS), Wound 
Evaluation Scale(WES) and Vancouver Scar Scale (VSS). 
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Result 
The patient treated with Channa striatus spray displayed a better outcome in term of pain 
control compared to placebo. During analysis using repeated measure ANOVA, there was 
significant difference of patient’s pain score based on VAPS between Channa striatus spray 
and placebo (F-stat(df) = 4.80 (2), p-value = 0.010). In term of cosmetic outcome it showed a 
consistent significant better result in haruan spray group for all the 3 scoring system which is 
VACS,  (F-stat(df) = 2.68 (2) , p-value <0.001), WES (F-stat(df) = 3.09 (2), p-value = 0.048). 
and VSS , F-stat(df) = 1.72 (2) , p-value = 0.011).  
 
 
Conclusion 
Our study suggest that application of  Haruan Extract spray on clean wound has shown a 
significant better pain score result and cosmetic outcome on week 2, week 4 and week 6 
comparatively with placebo.  
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1.0 INTRODUCTION  
 
 
1.1 Introduction  
 
Channa striatus (Haruan), a fresh water fish indigenous to many tropical countries have long 
been regarded as valuable food fish in the Far East. Their flesh is claimed to be rejuvenating, 
particularly in recuperation from serious illness and in a post-natal diet. In Malaysia, it has 
always be a strong belief that Channa striatus enhance wound healing and a very powerful tool 
for recovery of health and injury. Since 1931 there has been in Malaysian literature discussing 
about wound treatment using Channa striatus. Several studies showed that it contained all the 
essential amino acids and fatty acids which uniquely capable of accelerating the wound healing 
(1, 2).  
 
Despite the wide-spread uses of this fish for medicinal purposes, there have been hardly any 
studies to establish the scientific basis for its claimed wound healing effects. In an animal study, 
Channa striatus extract has shown to increase the tensile strength of the surgically stitched 
wound.  It also has been formulated into aerosol/spray for drug delivery system to wound and 
burn treatment  (3, 4). Evaluation of the film properties from concentrate of aerosol had been 
done in other study (5). But the effect on human has not been done yet. Therefore the effects of 
Channa striatus extract in aerosol form on clean surgical wounds are evaluated in this study. 
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1.2 Literature review 
 
 
1.1) Definition of wound 
Wound is defined as a breakdown in the protective function of the skin; the loss of continuity of 
epithelium, with or without loss of underlying connective tissue following injury to skin or 
underlying tissue or organ caused by surgery, a blow, a cut, chemicals, heat, friction, pressure or 
as a result of a disease. i.e. carcinoma, leg ulcer. 
 
1.2) Wound classification 
Wound can be classify based on (6-8) 
 
a) Etiology (e.g. : surgical,crush injury,) 
b) Morphology (e.g. : degloving, laceration, abrasion) 
c) Contamination (e.g. : clean, clean-contaminated, contaminated or dirty) 
d) Complexity (e.g. : simple, complex, complicated) 
e) Thickness (e.g. : superficial, partial thickness, full thickness) 
 
1.3) Wound healing process 
In healing process, wounds are either closed by primary intention or delayed primary closure. It 
also can left to heal by secondary intention.(9, 10). Wound healing is a dynamic process which 
can be divide into three phases. It is critical to remember that wound healing is not linear and 
often wounds can progress both forwards and back through the phases depending 
upon intrinsic and extrinsic factor within the patient(11, 12) 
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The phases of wound healing are (13) : 
 Inflammatory phase 
 Proliferation phase 
 Maturation phase 
The inflammatory phase is the body’s natural response to injury. After initial wounding, the 
blood vessels in the wound bed contract and a clot is formed. Once haemostasis has been 
achieved, blood vessels then dilate to allow essential cells; antibodies, white blood cells, growth 
factors, enzymes and nutrients to reach the wounded area. This leads to a rise in exudate levels 
so the surrounding skin needs to be monitored for signs of maceration. It is at this stage that the 
characteristic signs of inflammation can be seen; erythema, heat, oedema, pain and functional 
disturbance. The predominant cells at work here are the phagocytic cells; 
‘neutrophils and macrophages’; mounting a host response and autolyzing any devitalized 
‘necrotic / sloughy’ tissue. 
During proliferation, the wound is ‘rebuilt’ with new granulation tissue which is comprised 
of collagen and extracellular matrix and into which a new network of blood vessels develop, a 
process known as ‘angiogenesis’. Healthy granulation tissue is dependent upon 
the fibroblast receiving sufficient levels of oxygen and nutrients supplied by the blood vessels. 
Healthy granulation tissue is granular and uneven in texture; it does not bleed easily and is pink / 
red in colour. The colour and condition of the granulation tissue is often an indicator of how the 
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wound is healing. Dark granulation tissue can be indicative of poor perfusion, ischaemia and / or 
infection. Epithelial cells finally resurface the wound, a process known as ‘epithelialization’. 
Maturation is the final phase and occurs once the wound has closed. This phase involves 
remodeling of collagen from type III to type I. Cellular activity reduces and the number of blood 
vessels in the wounded area regress and decrease. 
1.4) Channa Striatus ( Haruan)   
 
Figure 1: Channa striatus (Haruan Fish) 
Channa Striatus is a fresh water species which also knows as snake head fish or known as 
Haruan in Malay. It is indigenous species to many tropical countries such as India, Thailand, 
Malaysia, and Indonesia. It belongs to Channidea family and it is carnivorous fish. 
 
1.5) Traditional believe on Channa striatus  
Traditionally Malay and Chinese community believe eating Channa striatus during postpartum 
period has a good effect on the post-delivery wound. It also believe that   Channa striatus act as 
energy booster meal. A study done among Chinese respondents in a Kuala Lumpur maternity 
hospital involved questions on the consumption of Channa striatus.(14) 
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1.6) Nutrition composition of Channa striatus  
Study found that Channa Striatus extract to have rich in amino acids, a nonessential 
amino acid which  glutamic acids arginine and aspartic acid  (15) .Others were listed in the table 
below. 
 
 
 
Table 1. Composition of amino acids and fatty acid in Channa striatus extract 
   Fillet   Roe   Mucus 
Amino acids  Glycine 
   Glutamic acid       (No study)  (No study) 
Arginine 
Aspartic acid 
 
Fatty acids  Eicosapentaenoic    Eicosapentaenoic    Oleic acid 
   Acid (EPA)   Acid (EPA)  Linoleic acid 
   Docosahexaenoic  Docosahexaenoic 
   Acid (DHA)  Acid (DHA) 
   Palmitic acid  Hexadecanoid acid 
   Oleic acid  Oleic acid 
   Stearic acid  Linoleic acid 
   Arachidonic acid 
 
 
Adopted from (16) 
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1.7) Composition of Channa striatus spray 
Haruan water extract has been formulated in an aerosol system which can produce a film for 
wound dressing. It was manufactured by Skin Fix Company. Haruan spray has been evaluated 
for the possibility to cause irritation reaction or toxic response however from three experiments 
were carried out to evaluate the safety of Haruan spray which are Primary Skin Irritation test, 
Intracutaneous test and Systemic Injection test, the result shows that Haruan spray gave no 
significant responses to all the above tests (17, 18). In 2011, Febriyenti have formulated an 
aerosol concentrate containing a mixture of haruan extract and a film-forming polymer. The 
concentrate when sprayed on the wound formed a thin layer of dressing and the added haruan 
extract proved to enhanced the healing process as proven by Baie and Sheikh studied the wound 
healing effect of C. striatus in Sprague-Dawley rats  (19). 
 
1.8) Channa striatus in as anti-microbial 
As a part of the wound healing process, antimicrobial activity is equally important. The 
antimicrobial properties of the skin and intestinal mucus of different Channa sp. viz: C. striatus, 
Channa micropeltes, Channa marulius, Channa punctatus and Channa gachua have been 
studied by CARE research team. The investigation showed a broad spectrum of antibacterial 
activity of skin mucus against Aeromonas hydrophila ,Pseudomonas aeruginosa and Vibrio 
anguillarum.(20) 
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1.9)  Antinociceptive properties Haruan  
The analgesic or antinociceptive effect were being studied by a few researchers. For instance, 
Mat Jais et al (1997) investigated the antinociceptive effects in mice with a view to establishing 
the scientific basis of pain-relieving activities where the study showed that both the fillet and 
mucus of Channa striatus were found to exhibit a concentration dependent antinociceptive 
activity (21).   There are evidences for arachidonic acid of haruan enhancing the activity of other 
antinociceptive agents such as morphine (21). 
 
 
 
1.3 Rationale of Study  
 Clean surgery procedure is one of major bulk of general surgery work load. It occupy 
almost 40% of all elective case. Post-operative pain and cosmetic outcome is one of major 
concern for the patient and potentially debilitating. Previous animal study has proven that haruan 
extract has improved tissue healing. However there is no human study done regarding the effect 
of haruan spray on cosmetic outcome and pain contral. It is clinically useful if we can identify 
the effectiveness of haruan extract spray on clean wound, which can be potentially extend to 
clean contaminated wound in future.    
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2-STUDY PROTOCOL 
2.1- DOCUMENT SUBMITED FOR ETHICAL APPROVAL 
A Prospective Double-Blinded Randomized Controlled Trial of the Efficacy of 
Haruan (Channa striatus) Spray on Wounds. 
 
 
Background/Introduction 
 
 In Malaysia, it has always be a strong belief that Haruan enhances wound healing and act 
as a very powerful tool for recovery of health and injury. Since 1931 there has been in Malaysian 
literature talking about wound treatment using Haruan. Several studies have been carried out to 
examine the efficacy and contents of Haruan meat. Indeed, the Haruan did contain all the 
essential amino acids and fatty acids uniquely capable of accelerating the wound healing. 
 
Channa striatus (Haruan), a fresh water fish indigenous to many tropical countries have 
long been regarded as valuable food fish in the Far East. Their flesh is claimed to be 
rejuvenating, particularly in recuperation from serious illness and in a post-natal diet. It is 
consumed for its putative effects on wound healing (22, 23). It is also used by the patients in the 
post-operative period in the belief that it promotes wound healing and reduces post-operative 
pain and discomfort. This fish is known to contain polyunsaturated fatty acids that can regulate 
prostaglandin synthesis and hence induce wound healing (24). Certain amino acids like glycine, 
aspartic and glutamic acid are also known to play important roles in the process of wound 
healing (25-27).  
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Despite the wide-spread uses of this fish for medicinal purposes, there have been hardly 
any studies to establish the scientific basis for its claimed wound healing effects. Previously (22) 
reported that the fatty acid composition of Haruan may account for the promotion of wound 
healing process. Gam et al. (28) reported that there are no significant differences in the content of 
amino acid and fatty acid compositions in this snakehead fish of various sizes and obtained at 
different times of the year (29).  
Cream extracts of Haruan tissues contain high levels of arachidonic acid, a precursor of 
prostaglandin, essential amino acids (particularly glycine) and polyunsaturated fatty acids 
necessary to promote prostaglandin synthesis. Treating wounds with these extracts has been 
demonstrated to promote synthesis of collagen fibers better than standard use of Cetrimide, an 
antimicrobial quaternary ammonium compound. In that study, Haruan extract was shown to 
increasing the tensile strength of the surgically stitched wounds when compared to the those 
treated with Cetrimide cream (30).  
 
Haruan extract have also been formulated into aerosol/spray for drug delivery system to 
wound and burn treatment  (3, 4). Evaluation of the film properties from concentrate of aerosol 
had been done in other study (5). But the effect on human has not been done yet. Therefore the 
effect of Haruan extract in aerosol form for incision/surgery wounds will be evaluated in this 
study. 
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Objectives of Study 
 Main Objectives 
 1) To evaluate the effectiveness of  Channa Striatus (Haruan) extract spray versus placebo in 
term of healing process and wound aesthetic appearance on clean surgical wounds 
 
 Specific Objectives 
1) To compare the effect of Haruan spray on patient’s pain score based on Visual Analogue Pain 
Score (VAPS). 
 
2) To compare the difference between Channa Stiatus extract  spray and placebo in term of 
cosmetic outmoce  based on Visual Analogue Cosmetic Scale  (VACS) and Wound Evaluation 
Scale (WES). 
 
3) To evaluate the resultant scars based on Vancouver Scar Scale (VSS). 
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Research Methodology 
 
Study Subject/Source Population 
 
This is a randomized, prospective, clinical study to evaluate the effect of topical administered 
Haruan (Channa striatus) extract in aerosol/spray form with the effect of placebo (spray without 
Haruan extract).  Subjects will be recruited from clinic of General Surgery (SOPD), Universiti 
Sains Malaysia (convenience based sampling). These patient are scheduled for an elective 
operation with clean incisional wound that are primarily sutured, are subjected to face to face 
interview to enquire about their suitability of the study. Eligible subjects consenting to 
participate will be randomly assigned to one of the two groups:  
 
GROUP 1: Subjects receiving Haruan spray  
GROUP 2: Subjects receiving placebo spray  
 
 
 
Subject must fulfill each of the following criteria for inclusion into this study. 
a. Age   18 and  50 years 
b. Subject who has given written informed consent to participate   in the study and 
understand the nature of the study 
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Exclusion Criteria 
 
a. Taking any form of  herbal extract in the last 3 months before study entry and during 
the study period 
b. History of drug or alcohol abuse. 
c. Patient taking warfarin or heparin 
d. Clinical relevant cardiovascular, gastrointestinal, hepatic, neurologic, endocrine, 
haematologic, connective tissue disease or other major systemic diseases that would 
influence the interpretation of results 
e. Patients with medical disorder requiring steroid or immunosuppressive therapy with 
delay wound healing 
f. Patient with chronic cough or other condition which may cause a rise in intra-
abdominal pressure 
g. Presence of any congenital anterior abdominal wall defects. 
h. Patient with evidence of secondary infection post treatment. 
i. Mental condition rendering the subject unable to understand the nature, scope and 
possible consequences of the study. 
j. Evidence of uncooperative attitude, including poor compliance including inability to 
attend follow-up visit. 
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Method of assigning subjects to treatment and placebo groups 
Subject eligibility will be established before treatment randomization. Subject number will be 
allocated strictly sequentially, as subjects are eligible for randomization. A randomization 
method is by using randomization software at www.randomization.com. Number that has 
been choosen by the software will determine either the patient will get treatment A or 
treatment B.  None of the investigators will know the randomization scheme. 
 
Blinding and procedures for breaking the blind 
This is double blinded study and once a subject has been randomized, the study treatment that 
they will receive will not be known by both the subject and the investigator. 
 
Patient’s withdrawal 
The investigator may cease study treatment and withdrew the subject or the subject may 
withdraw herself from participation in the study at any time.  The reason for the withdrawal 
of a patient will be recorded in the CRF.  Subject will be followed-up for a minimum of 42 
days ( 6 weeks)  following the last dose of study drug.  
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Possible reasons for patient withdrawal include: 
a. The need to take medication, which may interfere with study measurements.  
b. Patient experiences an intolerable / unacceptable adverse event 
c. Patient exhibits non-compliance with the protocol 
d. Patient unwilling to proceed and / or consent is withdrawn 
e. Investigator withdraws patient for reasons unrelated to the study drug (e.g. 
undercurrent illness) 
 
Investigational products 
 
The topical administered Haruan spray and placebo (spray without Haruan extract) will be 
prepared in GMP Laboratory, School of Pharmacy Universiti Sains Malaysia.  
 
Doses and treatment regimens 
 
The treatment group will be sprayed with Haruan spray once a day while the placebo group 
will be sprayed with placebo spray (spray without Haruan extract) once a day. 
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Data Collection Procedure 
 
 Basic demographic data will be collected from the patient and surgical procedure, indication 
and method of wound closure will be gathered. The wound assessment will be performed by 
clinical assessment using Visual Analogue Cosmetic Scale (VACS) and Wound Evaluation 
Scale (WES) by the investigators and also by the patient using Visual Analogue Pain Score 
(VAPS).   
A photo of the wound will be taken serially at every visit and assess by two independent 
investigators using VACS and WES.  
Haruan spray or placebo spray will be used to protect the wound after post-operative wound 
inspection. All subjects will be instructed to take normal diet during the study period and will 
not be allowed to take any other herbal products orally or consumed C. striatus.  
The cosmetic assessments of the wound will be done by the investigator who is part of the 
Clinical Trial Team. It will be done on week 2, week 4 and week 6 post operations. Subjects 
will be thoroughly examined by Medical specialists or Medical officers who are part of the 
Clinical Trial Team at every visit. 
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Sample Size Determination 
The sample sizes are calculated based on two means formula,(using G Power software) the 
power of the study taken at 90% and alpha (type one error) as 0.5%. The calculations are 
based on previous study (2, 31) .  
Power         = 90% 
 Type 1 error (α)        = 0.5% 
 SD         = 14mm 
 Expected detectable of mean difference between group  = 10mm 
The sample size required for both study limb   = 92 
Assuming 10% dropped out rate,     = 10 
Total number participants required for the study  = 102 
Computer calculation 
F tests - ANOVA: Repeated measures, between factors 
Analysis: A priori: Compute required sample size  
Input:  Effect size f    = 0.25 
  α err prob    = 0.05 
  Power (1-β err prob)                 =      0.90 
  Number of groups   = 2 
  Repetitions    = 3 
  Corr among rep measures  = 0.3 
Output: Noncentrality parameter λ  = 10.781250 
  Critical F    = 3.946876 
  Numerator df    = 1.000000 
  Denominator df   = 90.000000 
  Total sample size   = 92 
Actual power    = 0.901176 
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Expected results table  
 
Table 2: Comparison of mean of the wound aesthetic appearance using VAC Scale among 
different treatment groups based on time 
 
Time Treatment group Mean VAC scale 95% CI 
 
Week 2 Haruan 3 2,4 
 Control 7 6,8 
Week 4 Haruan 2 1,3 
 Control 5 4,6 
Week 6 Haruan 1 1, 
 Control 4 2,4 
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Flow Chart 
 
Haruan Spray Versus Placebo 
 
                                        Randomization of patients to 2 arms 
          Based on randomization software 
                                                              
                                              (Either Haruan spray or placebo) 
                                           
 
Treatment initiated post op after wound inspection (day 3) until 2nd week 
                        
 
   The wound treated with the study material daily dosing 
 
Wound assessment on 2nd, 4th and 6th weeks, VAPS were ask to patient, photograph will be 
taken and assessed based on VACS, VSS and WES 
 
                                        Data collection and statistical analysis 
Report and manuscript for publication 
 
 
 
 
 
 
 
 
Identification of patients with a clean surgical wound closed 
primarily 
 
Patients satisfying inclusion and exclusion criteria 
Information sheet & informed consent obtained 
Patient numbered sequentially (n=102) 
 
 
 TREATMENT A   
N= 51 
TREATMENT B 
N = 51 
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Privacy and Confidentiality. 
 
Privacy and the confidentiality of the data will be protected. Data collected will be stored in hard 
copy and will only be accessible to the research team. Identifying information will be kept by 
researcher during the data collection phase for tracking purposes only. 
 
 
 
Gannt Chart 
 
Milestone 
 
6 month ( June  2015): 60 % subject has been recruited, 25 % completed the wound investigation 
12 month (Dec 2015) : 100% subject has been recruited and completed the wound investigation 
18 month (June 2016) : Completed the data analysis 
24 month (Dec 2016) : Completed the project report and publication. 
 
 
                                       2015                                                       2016                                                                                                                
No Activity J F M A M J J A S O N D J F M A M J J A S O N D 
1. Subject 
recruitment  
and dispensing 
of medication 
 
                        
2. Follow up/ 
questionnaires, 
wound 
investigations 
                        
3. Data analysis                         
4. Report and  
publication 
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Performa 
 
Patient Study Number: 
Age: 
Gender: M/F 
Race:M/C/I/others 
Type of surgery: Hernioplasty/Exision Biopsy/Others 
Location: neck/chest/abdomen/inguinal 
Length of wound:           mm   
Wound Complication:Heal/infected/dehiscence   
  
Visual Analogue Pain Score (VAPS) 
 Poor        0 _____________________________________ 10           Excellent  
  
       /10 
 
  
 
 
 
 
           
Visual Analogue Cosmetic Scale (VACS) 
 Poor        0 _____________________________________ 10           Excellent  
                                          /10  
 
 
 
 
 
 
 
 
Week Week2 Week 4 Week 6 
Score    
Week Week2 Week 4 Week 6 
Score    
21 
 
Vancouver Scar Scale 
Pigmentation Vascularity Pliability Height 
0 Normal 0 Normal 0 Normal 0 Normal 
1 Hypopigmentation 1 Pink 1 Supple 1 <2mm 
2 Hyperpigmentation 2 pink to red 2 Yielding 2 2-5mm 
 3 Red 3 Firm 3 >5mm 
 4 Red to purple 4 Banding  
 5 Purple 5 Contracture  
 
     /13 
 
 
 
Wound Assessment Scale 
 At 2 
weeks* 
At 4 
weeks* 
At 6 
weeks* 
Stepoff border    
Contour irregularity-puckering    
Scar width –greater than 2 mm    
Edge inversion-sinking,curling    
Inflammation –redness, discharge    
Overall cosmesis    
Total score    
/6 
 
ASSESSOR NAME : ___________________________________________ 
 
 
 
 
 
 
 
 
Week Week2 Week 4 Week 6 
Score    
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2.2 ETHICAL APPROVAL LETTER 
 
 
 
 
 
I
Jawatankuasa Etika Penyelidika n Manusia USM (JEPeM) 
Human Research Ethics Com mittee USi\1 (HREC) 
25'" February 2015 
Dr. Rosnelifaizur Ramely 
Department of Surgery 
School of Medical Sciences 
Universiti Sa ins Malaysia 
16150 Kubang Kerian, Kelantan. 
JEPeM Code : USM/JEPeM/1403124 
Universili Sains Malaysia 
l\~mptL1 Kesihlllnn, 
1 fi J.f,(} l\ubowg: Hcrian. 
Kclanmn. M~hay$i~. 
T: 1)()9 - i'(i";' jO()() s.nnh. ~.i,j J.l~~l(i':! 
F': tiO!J- 767 !!:i;) l 
F..: jt:pt·m(8:1L"'olll.tn)' 
www.j~rn.kk.tL'iJn.my 
Protocol Title : A Prospective Double-Blinded Randomized Controlled Trial of the Efficacy of 
Haruan (Channa Striatus) Spray on Wounds. 
Dear Dr., 
We wish to inform you that your study protocol has been reviewed and is hereby granted approval 
for implementation by the Jawatankuasa Etika Penyelidikan Manusia Universit i Sains Malaysia 
(J EPeM-USM). Your study has been assigned study protocol code USM/ JEPeM/1403124, which 
should be used for all communication to the JEPeM-USM relat ed to this study. Th is ethical clearance 
is va lid from March 2015 until February 2016. 
The following documents have been approved for use in t he study. 
1. Research Proposa I 
In addition to the abovementioned documents, the following technical document was included in 
t he review on which this approval was based: 
1. Patient Information Sheet and Consent Form (English version) 
2. Patient Information Sheet and Consent Form (Malay version) 
Attached document is the list of members of JEPeM-USM present during the fu ll board meeting 
reviewing your protocol. 
While the study is in progress, we request you to submit to us the following documents: 
1. Progress report using the JEPeM-USM FORM 3(8) 2014: Continuing Review Application 
Form every 1 year from date of approval (NOTE: In view of active ethica l clearance, this 
report is mandatory even if the study has not started or is still awaiting release of funds.) 
2. Any changes in the protocol, especially those that may adversely affect the safety of the 
participants during the conduct of the trial including changes in personnel, must be 
submitted or reported using JEPeM-USM FORM 3(A) 2014: Study Protocol Amendment 
Submission Form. 
3. Revisions In the Informed consent form using the JEPeM-USM FORM 3(A)2014: Study 
Protocol Amendment Submission Form. 
4. Reports of adverse events {if any) including from other study sites {nat ional, international) 
using the JEPeM·USM FORM 3{G) 2014: Adverse Events Report. 
5. Notice of early termination of the study and reasons for such using JEPeM-USM FORM 3(E) 
2014. 
6. Any event which may have ethical significance. 
7. Any information which is needed by the JEPeM-USM to do ongoing review. 
8. Not ice of time of completion of the study using JEPeM-USM FORM 3{C) 2014: Final Report 
Form. 
<Approvai><Dr. Rosneliraizur><USMIJEPeM/1403124 Poagelof 2 
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9. Application for renewal of ethical clearance 90 days before the expira tion date of this 
approval through submission of JEPeM-USM FORM 3{B) 2014: Continuing Review 
Application Form. 
Please note that forms may be downloaded from the JEPeM-USM website: www.jepem.kk.usm.mv 
Jawatankuasa Etika Penyelidikan (Manusia), JEPeM-USM is in compliance with the Declaration of 
Helsinki, International Conference on Harmonization (ICH) Guidelines, Good Clinical Practice (GCP) 
Standards, Council for International Organizations of Medical Sciences (CIOMS) Guidelines, World 
Health Organization (WHO) Standards and Operational Guidance for Ethics Review of Health-Related 
Research and Surveying and Evaluating Ethical Review Practices, EC/IRB Standard Operating 
Procedures (SOPs), and Local Regulations and Standards in Ethical Review. 
Thank you. 
" ENSURING A SUSTAINABLE TOMORROW" 
Very truly yours, 
PRO~N ROSTENBERGHE 
Chairperson 
Jawatankuasa Etika Penyelidikan (Manusia) JEPeM 
Universiti Sains Malaysia 
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